Today’s Rating Change: EU: Align Tech (ALGN)’s Stock Had Its Buy Rating Restated at Stifel in Report Issued Today. Has $110.0 Target

November 28, 2016 - By Hazel Jackson

Today's Rating Change: EU: Align Tech (ALGN)'s Stock Had Its Buy Rating Restated at Stifel in Report Issued Today. Has $110.0 Target

Align Tech (ALGN) Rating

In a note sent to investors on Monday, 28 November, Align Tech (ALGN) stock Buy was restate by Analysts at Stifel. They currently have a $110.0 PT on the stock. Stifel’s PT would suggest a potential upside of 14.36% from the company’s last stock close.

The stock increased 0.67% or $0.64 during the last trading session, hitting $96.19. About 400 shares traded hands. Align Technology, Inc. (ALGN) has risen 29.50% since April 25, 2016 and is uptrending. It has outperformed by 23.48% the S&P500.

Analysts await Align Technology, Inc. (NASDAQ:ALGN) to report earnings on January, 26. They expect $0.67 EPS, up 11.67% or $0.07 from last year’s $0.6 per share. ALGN’s profit will be $53.77M for 35.89 P/E if the $0.67 EPS becomes a reality. After $0.63 actual EPS reported by Align Technology, Inc. for the previous quarter, Wall Street now forecasts 6.35% EPS growth.

Insitutional Activity: The institutional sentiment increased to 1.41 in 2016 Q2. Its up 0.16, from 1.25 in 2016Q1. The ratio increased, as 33 funds sold all Align Technology, Inc. shares owned while 99 reduced positions. 62 funds bought stakes while 103 increased positions. They now own 64.99 million shares or 4.19% less from 67.84 million shares in 2016Q1.

Quantbot Technology Limited Partnership accumulated 7,456 shares or 0.06% of the stock. The Virginia-based Motley Fool Asset Mgmt Lc has invested 0.87% in Align Technology, Inc. (NASDAQ:ALGN). Rhumbline Advisers has 129,108 shares for 0.03% of their US portfolio. Healthcor Mngmt L P last reported 41,730 shares in the company. Daruma Capital Mngmt Llc accumulated 42,420 shares or 0.22% of the stock. First Ltd Partnership holds 0.09% or 374,107 shares in its portfolio. Retirement Systems Of Alabama owns 318,825 shares or 0.15% of their US portfolio. State Street accumulated 2.05M shares or 0.02% of the stock. Cap Financial Advisers Ltd Liability Company owns 141,455 shares or 0.12% of their US portfolio. Catalyst Capital Advisors Limited Liability holds 0.06% or 4,350 shares in its portfolio. Moreover, Metropolitan Life Insurance Communications Ny has 0.04% invested in Align Technology, Inc. (NASDAQ:ALGN) for 71,814 shares. Invesco reported 795,758 shares or 0.02% of all its holdings. The West Virginia-based Wesbanco National Bank & Trust has invested 0.06% in Align Technology, Inc. (NASDAQ:ALGN). Meeder Asset Management holds 0% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN) for 3 shares. Swiss Fincl Bank has 120,264 shares for 0.02% of their US portfolio.

Insider Transactions: Since August 9, 2016, the stock had 0 buys, and 7 sales for $12.87 million net activity. Olson Jennifer sold $74,545 worth of stock or 799 shares. The insider Tay Julie sold 3,000 shares worth $277,800. LACOB JOSEPH sold $5.72 million worth of stock. Shares for $979,130 were sold by SANTORA GREG J. 11,152 shares were sold by WHITE DAVID L, worth $1.07 million on Friday, November 18. Relic Zelko also sold $1.30 million worth of Align Technology, Inc. (NASDAQ:ALGN) on Monday, August 15.

Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing digital services used in dentistry, orthodontics and dental records storage. The company has a market cap of $7.72 billion. The Firm operates through two divisions: Clear Aligner segment and Scanner and Services (Scanner) segment. It has a 40.99 P/E ratio. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Express/Lite, Teen, Assist and Vivera Retainers, along with its training and ancillary products for treating malocclusion.

According to Zacks Investment Research, “Align Technology Inc. designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. The System corrects malocclusion using a series of clear, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, the System significantly reduces the aesthetic and other limitations associated with braces. The Invisalign System also offers orthodontists a new means of carrying out their diagnosis and treatment planning processes.”

ALGN Company Profile

Align Technology, Inc., incorporated on April 3, 1997, designs, makes and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Firm operates through two divisions: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Express/Lite, Teen, Assist and Vivera Retainers, along with its training and ancillary products for treating malocclusion. The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Company’s iTero scanner is used by dental professionals, and labs and services for restorative and orthodontic digital procedures, as well as Invisalign digital impression submission.

More news for Align Technology, Inc. (NASDAQ:ALGN) were recently published by: Fool.com, which released: “Align Technology Inc. Beats Q3 Expectations With Record Invisalign Volume” on November 07, 2016. Fool.com‘s article titled: “International Sales Help Align Technology, Inc. in Q2” and published on July 29, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>